Format

Send to:

Choose Destination
See comment in PubMed Commons below
Pharmacol Ther. 2007 Feb;113(2):442-58. Epub 2006 Nov 29.

The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO.

Author information

  • 1Division of Cardiology, Department of Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA. npaolocc@jhmi.edu

Abstract

Nitroxyl (HNO), the 1-electron reduced and protonated congener of nitric oxide (NO), has received recent attention as a potential pharmacological agent for the treatment of heart failure and as a preconditioning agent for the mitigation of ischemia-reperfusion injury. Interest in the pharmacology and biology of HNO has prompted examination, or in some instances reexamination, of many of its chemical properties. Such studies have provided insight into the chemical basis for the biological effects of HNO, although the biochemical mechanisms for many of these effects remain to be established. In this review, a brief description of the biologically relevant chemistry of HNO is given, followed by a more detailed discussion of the pharmacology and potential toxicology of HNO.

PMID:
17222913
[PubMed - indexed for MEDLINE]
PMCID:
PMC3501193
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Write to the Help Desk